Erythrocyte Membrane Camouflaged Metal–Organic Framework Nanodrugs for Remodeled Tumor Microenvironment and Enhanced Tumor Chemotherapy
- 23 October 2021
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 32 (6), 2107791
- https://doi.org/10.1002/adfm.202107791
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (91959124, 81671753, 32071406, 21804104, 51922077, 51872205)
- China Postdoctoral Science Foundation (2019M650259)
- Fundamental Research Funds for the Central Universities (JB211201, JB211202, JB211204, JC2112)
- Excellent Young Talents Fund Program of Higher Education Institutions of Anhui Province (2017YQ050)
- Instituto de Pesquisa Translacional em Saúde e Ambiente na Região Amazônica (TMSK‐2020‐012)
- Postdoctoral Science Foundation of Jiangsu Province (2019M650259)
- Natural Science Foundation of Shaanxi Province (2021JM‐147)
This publication has 47 references indexed in Scilit:
- The roles of TGFβ in the tumour microenvironmentNature Reviews Cancer, 2013
- TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stromaProceedings of the National Academy of Sciences of the United States of America, 2012
- Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platformProceedings of the National Academy of Sciences of the United States of America, 2011
- Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumorsProceedings of the National Academy of Sciences of the United States of America, 2011
- Doxorubicin in Combination with a Small TGFβ Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse ModelsPLOS ONE, 2010
- Drug Resistance and the Solid Tumor MicroenvironmentJNCI Journal of the National Cancer Institute, 2007
- Tumor microenvironment: The role of the tumor stroma in cancerJournal of Cellular Biochemistry, 2007
- Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signalingProceedings of the National Academy of Sciences of the United States of America, 2007
- TGFβ: the molecular Jekyll and Hyde of cancerNature Reviews Cancer, 2006
- The ABC Transporter Abcg2/Bcrp: Role in Hypoxia Mediated SurvivalBioMetals, 2005